Background: The susceptibility vessel sign (SVS) on MRI has been linked to functional outcomes and reperfusion success after endovascular treatment (EVT), suggesting its potential as a prognostic marker. This updated systematic review and meta-analysis aimed to evaluate the prognostic and etiological significance of SVS in acute ischemic stroke (AIS). Methods: We conducted a systematic search of PubMed, Embase, and Cochrane in May 2025. Eligible studies included post-hoc analyses of randomized controlled trials (RCTs) and observational studies of AIS patients treated with EVT and/or intravenous thrombolysis (IVT). Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Primary outcome was successful reperfusion (mTICI 2b-3). Secondary outcomes included functional independence (modified Rankin Scale [mRS] score 0–2), mortality, stroke etiology, and time metrics. Results: Eighteen studies ( n = 2602) were included. Overall, SVS was not associated with higher reperfusion rates (12 studies; n = 2083; RR: 1.01; 95% CI: 0.93–1.10; p = .832; I 2 = 56.0%), except in the SWI subgroup (2 studies; RR: 1.17; 95% CI: 1.02–1.34; p = .022; I 2 = 0.0%). SVS + was linked to lower 90-day mortality in anterior circulation strokes (3 studies; n = 865; RR: 0.52; 95% CI: 0.36–0.74; p < .001; I 2 = 0%), improved 90-day functional independence in Western populations (7 studies; n = 1481; RR: 1.22; 95% CI: 1.01–1.47, p = .039; I 2 = 37.7%), and in cardioembolic stroke etiology using GRE (9 studies; n = 1058; RR: 1.29; 95% CI: 1.05–1.57; p = .014; I 2 = 36.3%). The mean time from onset to treatment was 238.19 minutes ± 147.5. Conclusions: Although SVS + did not predict reperfusion, it was associated with better functional outcomes in Western populations, particularly in cardioembolic stroke, and lower mortality, thereby reinforcing its prognostic value. MRI protocols did not delay treatment, but high heterogeneity limits certainty, highlighting the need for prospective studies.
1 April 2026 in CardioVascular and Interventional Radiology
Introduction: Preoperative embolization reduces intraoperative blood loss (IBL) in meningioma treatment, but the optimal embolic material remains uncertain. This systematic review and meta-analysis compares the effectiveness and safety of particle versus liquid embolic agents in the preoperative embolization of meningiomas. Methods: PubMed, Cochrane, Embase, and Scopus were searched for studies comparing particles and liquid embolic agents in patients undergoing preoperative embolization of meningiomas. Primary outcomes included the degree of devascularization, IBL, ischemic events, and overall complications. The risk of bias was assessed using the ROBINS-I. Statistical analyses were conducted using R. Results: The analysis included four studies, covering a total of 1827 patients. Particles were associated with a significantly lower incidence of operative complications (OR = 0.35; 95% CI 0.20–0.62; p < 0.001; I 2 = 0.0%). The other outcomes did not differ between groups. Regarding IBL, no significant difference was observed between particulate and liquid embolic agents (MD = −65.01 mL; 95% CI −237.01–107.00; p = 0.46; I 2 = 77.8%). Conclusion: Our systematic review and meta-analysis indicate no significant differences between particulate and embolic agents; however, particulate agents were associated with a lower incidence of overall complications, suggesting a potential advantage in perioperative safety.
16 May 2026 in Journal of Vascular and Interventional Radiology
To evaluate the efficacy of tract embolization in preventing pneumothorax and chest tube placement after CT-guided percutaneous lung biopsy. PubMed, Embase, Web of Science, and Cochrane Library were searched through March 2025 for studies comparing tract embolization versus no embolization. RR with 95% CI were pooled using random-effects models. ARR and NNT were calculated using the Control Event Rate (CER). Subgroup analyses were performed by embolic agent, study design, and chest tube placement criteria. Certainty of evidence was assessed using the GRADE approach. All analyses were conducted in R. A total of 26 studies comprising 10,689 patients were included, of whom 5,066 underwent TE. TE was associated with a lower risk of pneumothorax (RR 0.59; 95% CI 0.53-0.65; p<0.001; I2=33%), with blood patch (RR 0.62; 95% CI 0.51-0.76; I2=48.9%) and gelfoam (RR 0.56; 95% CI 0.47-0.66; I2=31.8%). TE also reduced chest tube placement (RR 0.47; 95% CI 0.37-0.58; p<0.001; I2=32.9%), with blood patch (RR 0.47; 95% CI 0.33-0.67; I2=30%) and gelfoam (RR 0.48; 95% CI 0.31-0.73; I2=42.3%). Tract embolization after CT-guided percutaneous lung biopsy was associated with reduced pneumothorax and chest tube placement rates, with consistent reductions across blood patch, gelatin-based agents, and hydrogel. These findings support tract embolization as an effective adjunct to reduce procedure-related complications.
1 September 2025 in Clinical Neurology and Neurosurgery